Identity and research family
GHRP-2, also called pralmorelin, is studied as a synthetic agonist in the ghrelin / growth hormone secretagogue receptor system. The name describes a research relationship to GH release; it does not mean the peptide is growth hormone. It should also be distinguished from GHRH-related peptides, which approach the endocrine axis through a different signaling route.
What was measured in humans
A controlled experiment reported in 2005 studied seven lean healthy men and assessed food intake after GHRP-2 exposure. Participants consumed more food under the study conditions than with the comparator. This is an acute experimental observation in a very small, selected group. It is not evidence that every person will experience the same response or that the response translates into a beneficial long-term outcome.
Why the time scale matters
An experiment lasting hours can be useful for detecting a biological signal. It cannot answer the same questions as months of treatment with follow-up. A claim about body composition would need a suitable body-composition measurement, a relevant comparator and enough time to distinguish persistent change from short-term variation. A claim about recovery would need an explicit recovery endpoint rather than an assumption based on GH release.
Safety context requires its own evidence
The FDA compounding safety page includes GHRP-2 and identifies concerns that warrant attention. A regulatory safety discussion should be read separately from a paper demonstrating a hormone or appetite response. Neither the mechanism nor the existence of a human experiment establishes the quality or safety of a product currently advertised under the same name.
How to compare GHRP-2 with other peptides
Start with the receptor pathway and then compare the actual human studies. GHRP-6 and hexarelin may appear in the same broad literature, but a result for one should not be assigned to the others. Ipamorelin research in a postoperative population asks a different clinical question from an acute food-intake experiment in healthy men. Context belongs in the comparison table, not in a footnote.
Useful questions for the original paper
Check the allocation procedure, whether participants and investigators were blinded, how food consumption was measured and how hormone sampling related to the meal. Consider whether a small, homogeneous sample can address the population named in a claim. These questions help separate a real experimental finding from an unsupported extension into general wellness advice.
